{
    "organizations": [],
    "uuid": "b9205ed98ffdb741b357aaff86e8880498e1d509",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-initiator-pharma-to-carry-out-issu/brief-initiator-pharma-to-carry-out-issue-with-proceeds-of-about-sek-31-8-mln-before-issuing-costs-idUSFWN1PW08Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Initiator Pharma To Carry Out Issue With Proceeds Of About SEK 31.8 Mln Before Issuing Costs",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 6 (Reuters) - INITIATOR PHARMA A/S:\n* THE BOARD PROPOSES EXTRAORDINARY GENERAL MEETING TO DECIDE ON THE CONDUCTION OF A RIGHTS ISSUE OF UNITS\n* ISSUE TO BRING PROCEEDS OF ABOUT SEK 31.8 MILLION BEFORE ISSUING COSTS\n* ‍ISSUE PRICE: 6,60 SEK PER UNIT, CORRESPONDING TO 2,20 SEK PER SHARE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-06T15:54:00.000+02:00",
    "crawled": "2018-02-07T21:54:46.041+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "initiator",
        "pharma",
        "board",
        "proposes",
        "extraordinary",
        "general",
        "meeting",
        "decide",
        "conduction",
        "right",
        "issue",
        "unit",
        "issue",
        "bring",
        "proceeds",
        "sek",
        "million",
        "issuing",
        "cost",
        "price",
        "sek",
        "per",
        "unit",
        "corresponding",
        "sek",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}